Cataflam (Diclofenac potassium immediate-release tablets) for Rheumatoid Arthritis | myRAteam

Connect with others who understand.

sign up log in
About myRAteam
Powered By

Cataflam is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to relieve the signs and symptoms of rheumatoid arthritis. Cataflam is also referred to by its drug name, diclofenac potassium immediate-release tablets.

Cataflam belongs to a class of drugs called nonsteroidal anti-inflammatory drugs (NSAID). Cataflam is believed to work by reducing pain and inflammation caused by rheumatoid arthritis.

How do I take it?
Prescribing information states that Cataflam is taken orally three times per day. It is recommended to use the lowest possible dose to relieve symptoms while minimizing the risk of side effects.

Cataflam comes in the form of an oral tablet.

Side effects
The FDA-approved label for Cataflam lists common side effects including indigestion, gas, abdominal pain, nausea, vomiting, diarrhea, constipation, headache, dizziness, rashes, and itching.

Rare but serious side effects listed for Cataflam include heart attack, stroke, gastrointestinal bleeding and ulcers, kidney damage, severe skin reactions, and allergic reactions.

For more details about this treatment, visit:

Cataflam — Novartis

Cataflam — RxList

Continue with Facebook
Continue with Google
Your privacy is our priority. By continuing, you accept our Terms of Use and Privacy Policy.
Already a Member? Log in